Literature DB >> 9365774

Complete remission of AIDS-related Kaposi's sarcoma associated with undetectable human herpesvirus-8 sequences during anti-HIV protease therapy.

L Blum, C Pellet, F Agbalika, G Blanchard, P Morel, F Calvo, C Lebbé.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9365774

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  8 in total

1.  Human immunodeficiency virus replication in a primary effusion lymphoma cell line stimulates lytic-phase replication of Kaposi's sarcoma-associated herpesvirus.

Authors:  V Varthakavi; P J Browning; P Spearman
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

Review 2.  Viral infections of the gastrointestinal tract.

Authors:  R W Goodgame
Journal:  Curr Gastroenterol Rep       Date:  1999-08

3.  Occurrence of gastrointestinal opportunistic disorders in AIDS despite the use of highly active antiretroviral therapy.

Authors:  Klaus E Mönkemüller; Audrey J Lazenby; David H Lee; Robert Loudon; C Mel Wilcox
Journal:  Dig Dis Sci       Date:  2005-02       Impact factor: 3.199

4.  Inhibition of Kaposi's sarcoma-associated herpesvirus lytic replication by HIV-1 Nef and cellular microRNA hsa-miR-1258.

Authors:  Qin Yan; Xinting Ma; Chenyou Shen; Xu Cao; Ninghan Feng; Di Qin; Yi Zeng; Jianzhong Zhu; Shou-Jiang Gao; Chun Lu
Journal:  J Virol       Date:  2014-02-19       Impact factor: 5.103

5.  AIDS-associated Kaposi's sarcoma is linked to advanced disease and high mortality in a primary care HIV programme in South Africa.

Authors:  Kathryn M Chu; Gcina Mahlangeni; Sarah Swannet; Nathan P Ford; Andrew Boulle; Gilles Van Cutsem
Journal:  J Int AIDS Soc       Date:  2010-07-08       Impact factor: 5.396

Review 6.  Insights into the broad cellular effects of nelfinavir and the HIV protease inhibitors supporting their role in cancer treatment and prevention.

Authors:  Soren Gantt; Corey Casper; Richard F Ambinder
Journal:  Curr Opin Oncol       Date:  2013-09       Impact factor: 3.645

7.  Do antiretrovirals reduce the risk of non-AIDS-defining malignancies?

Authors:  Michael J Silverberg; Donald I Abrams
Journal:  Curr Opin HIV AIDS       Date:  2009-01       Impact factor: 4.283

8.  Randomized trial of paclitaxel versus pegylated liposomal doxorubicin for advanced human immunodeficiency virus-associated Kaposi sarcoma: evidence of symptom palliation from chemotherapy.

Authors:  Mary Cianfrocca; Sandra Lee; Jamie Von Roenn; Anil Tulpule; Bruce J Dezube; David M Aboulafia; Richard F Ambinder; Jeannette Y Lee; Susan E Krown; Joseph A Sparano
Journal:  Cancer       Date:  2010-08-15       Impact factor: 6.860
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.